Post date August 17, 2023 Experience RAPT Therapeutics $150 million at-the-market offering The shares are listed on the Nasdaq Global Market
Post date July 10, 2023 Experience Monitronics International emerges from chapter 11 We advised the ad hoc lender group that negotiated and backstopped the restructuring
Post date July 5, 2023 Experience Nextracker $662.5 million common stock offering We advised Nextracker on the SEC-registered secondary offering
Post date June 30, 2023 Experience Lucid Group $232 million strategic supply agreement with Aston Martin We are advising Lucid Group on the transaction
Post date June 5, 2023 Experience Lucid $3 billion public offering of stock and concurrent private placement We advised Lucid on the transactions
Post date May 18, 2023 Experience Texas Instruments $1.6 billion notes offering We advised Texas Instruments on its investment-grade debt offering
Post date May 17, 2023 Experience Monitronics International chapter 11 filing and DIP financing We are advising the ad hoc lender group that is backstopping the restructuring
Post date April 20, 2023 Experience Enovix $162.5 million convertible senior notes and capped call transactions The 3.00% convertible notes are due 2028
Post date April 17, 2023 Experience AN2 Therapeutics $100 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
Post date March 27, 2023 Experience Silicon Valley Bridge Bank strategic and regulatory advice We advised the bank on numerous issues leading up to the sale of deposits and certain assets to First Citizens by the FDIC